AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES
Report
- Report Number
- 2135147-2020-00092
- Event Type
- Injury
- Date Received
- March 3, 2020
- Date of Event
- December 1, 2016
- Report Date
- December 20, 2020
- Manufacturer
- AGA MEDICAL CORPORATION
- Product Code
- MAE
- PMA / PMN Number
- P020024
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TW
- Reporter Occupation
- PHYSICIAN
Narratives
CORRECTION INFORMATION FOR D2ADDITIONAL INFORMATION FOR G4, G7, H2, H10.
CORRECTION TO B5, D1, D4, G4, G7, H2, AND H10. AS REPORTED IN A RESEARCH ARTICLE, LEFT PULMONARY ARTERY OBSTRUCTION WERE NOTED DURING FOLLOW UP AFTER DEVICE IMPLANTATION. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE REMAINS IMPLANTED WAS NOT RETURNED FOR ANALYSIS. THE CAUSE OF THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED. PLEASE NOTE, PER THE INSTRUCTIONS FOR USE, 600419-004 VERSION A, " THE AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES IS CONTRAINDICATED FOR PATIENTS WHO WEIGH LESS THAN 6 KG AND ARE YOUNGER THAN 6 MONTHS IN AGE". AN INITIAL REVIEW OF COMPLAINTS DATA WAS REVIEWED ON 14 APRIL 2020 AS A COMPONENT OF THE COMPLAINT HANDLING RISK REVIEW PER WI 90591806. THE MEDICAL DEVICE PROBLEM AND AHO CODES ARE CONSISTENT WITH THE HAZARDS/HARMS IDENTIFIED FOR THIS PRODUCT FAMILY, AND NO NEW HAZARDS OR HARMS WERE IDENTIFIED.
IT WAS REPORTED THROUGH A RESEARCH ARTICLE IDENTIFYING AMPLATZER ADO II THAT MAY BE RELATED TO A SEVERE LEFT PULMONARY ARTERY OBSTRUCTION. DETAILS ARE LISTED IN THE ARTICLE, TITLED "DEVICE DEFORMATION AND LEFT PULMONARY ARTERY OBSTRUCTION AFTER TRANSCATHETER PATENT DUCTUS ARTERIOSUS CLOSURE IN PRETERM INFANTS". IT WAS REPORTED IN THE ARTICLE THAT IN (B)(6) 2016, 14 PATIENTS UNDERWENT TRANSCATHETER PATENT DUCTUS ARTERIOSUS (PDA) CLOSURE. AN 30 DAYS OLD PATIENT THAT WEIGHT 1136 GRAMS WITH PDA DIAMETER OF 1.89MM AND PDA LENGTH OF 7.89MM WAS IMPLANTED WITH A 4-4 AMPLATZER ADO II. DURING FOLLOW UP, SEVERE LEFT PULMONARY ARTERY OBSTRUCTION WAS OBSERVED. THE PATIENT WAS ASYMPTOMATIC AND NO INTERVENTION WAS PERFORMED.
AS REPORTED IN A RESEARCH ARTICLE, LEFT PULMONARY ARTERY OBSTRUCTION WERE NOTED DURING FOLLOW UP AFTER IMPLANTATION WITH A 4-4 AMPLATZER PICCOLO. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE REMAINS IMPLANTED WAS NOT RETURNED FOR ANALYSIS. A REVIEW OF THE MEASUREMENTS AS REPORTED FROM THE FIELD WAS PERFORMED. PER THE SIZING TABLE IN THE INSTRUCTIONS FOR USE, ARTEN600042307 VERSION A, THE CORRECT SIZE PICCOLO OCCLUDER FOR THE MEASUREMENTS PROVIDED WAS 04-02, SMALLER THAN THE IMPLANTED DEVICE. THE CAUSE OF THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED, HOWEVER THE IMPLANTATION OF A LARGER THAN RECOMMENDED DEVICE COULD HAVE CONTRIBUTED.
REFERENCE MANUFACTURING REPORT NUMBER: 2135147-2020-00090, 2135147-2020-00091, 2135147-2020-00093, 2135147-2020-00094. IT WAS REPORTED THROUGH A RESEARCH ARTICLE IDENTIFYING AMPLATZER PICCOLO THAT MAY BE RELATED TO A SEVERE LEFT PULMONARY ARTERY OBSTRUCTION. DETAILS ARE LISTED IN THE ARTICLE, TITLED "DEVICE DEFORMATION AND LEFT PULMONARY ARTERY OBSTRUCTION AFTER TRANSCATHETER PATENT DUCTUS ARTERIOSUS CLOSURE IN PRETERM INFANTS." IT WAS REPORTED IN THE ARTICLE THAT IN (B)(6) 2016, 14 PATIENTS UNDERWENT TRANSCATHETER PATENT DUCTUS ARTERIOSUS (PDA) CLOSURE. AN (B)(6) DAYS OLD PATIENT THAT WEIGHT (B)(6) GRAMS WITH PDA DIAMETER OF 1.89MM AND PDA LENGTH OF 7.89MM WAS IMPLANTED WITH A 4-4 AMPLATZER PICCOLO. DURING FOLLOW UP, SEVERE LEFT PULMONARY ARTERY OBSTRUCTION WAS OBSERVED. THE PATIENT WAS ASYMPTOMATIC AND NO INTERVENTION WAS PERFORMED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 242592 | AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES | OCCLUDER, PATENT DUCTUS, ARTERIOSUS | MAE | AGA MEDICAL CORPORATION | 9-PDA2AS-04-04-L |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 30 DA | Other |